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ABSTRACT
Background: Neurological disorders (ND) have a profound consequence on human produc-
tivity, quality of life and survival. There are limited data on the burden of ND in Tanzania due
to insufficient coverage of civil and vital registration systems.
Objectives: This study was conducted to estimate mortality of ND in all ages in Tanzania
using data from the Sample Vital Registration with Verbal Autopsy (SAVVY) study.
Methods: Multistage random sampling was employed to select 23 districts, 1397 census
enumeration areas and 154,603 households. During the baseline survey conducted between
2011 and 2014, deaths which occurred 12 months prior to the baseline survey were docu-
mented followed by verbal autopsy interviews. Causes of death were certified using
International Classification of Diseases.
Results: The baseline survey enrolled a total of 650,864 residents. A total of 6645 deaths were
reported to have occurred 12 months before the date of survey. Death certification was
available for 5225 (79%) deaths. The leading causes of death were cerebrovascular diseases
with a cause-specific mortality fraction (CSMF) of 1.64% (95% CI: 1.30–1.99) and 3.82% (95%
CI: 2.92–4.72) in all ages and adults older than 50 years, respectively. Stroke accounted for
92% of all cerebrovascular deaths. Mortality of epilepsy was estimated with a CSMF of 0.94%
(95% CI: 0.68–1.20); meningitis with a CSMF of 0.80% (95% CI: 0.56–1.04); cerebral palsy and
other paralytic syndromes with a CSMF of 0.46% (95% CI: 0.27–0.65); and intrauterine hypoxia
in neonates with a CSMF of 2.06% (95% CI: 1.12–3.01). Overall, mortality of ND was estimated
with a CSMF of 4.99% (95% CI: 4.40–5.58).
Conclusions: The SAVVY survey provides estimates of mortality burden of ND in Tanzania.
The study provides a basis for monitoring trends of ND and contributes to advancing
knowledge of the burden of diseases. Integrating morbidities measures into the SAVVY
design will provide comprehensive measures of burden of ND taking into account lifetime
disabilities created by ND.
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Neurological disorders (ND) have a profound conse-
quence on human productivity, quality of life and
survival in developed and developing countries. The
most prevalent ND globally include dementia (pro-
gressive memory loss); Parkinson’s (impaired motor
system); multiple sclerosis (problem with vision,
movement, sensation or balance); epilepsy (sudden
recurrence of unprovoked seizures); and stroke (two
or one sides paralysis or numbness).
Dementia and Parkinson’s disease are the most
common ND in most developed countries with
a reported increasing trend [1]. The increases in
ND’s mortality in developed countries are higher
than increases in other chronic diseases such as
cancer and diseases of circulation [2]. Substantial
proportions of neurological disorders in devel-
oped countries are thought to be attributed to
increased life expectancy (aging) and unhealthy
lifestyle [3].
In most developing countries, on the other hand,
etiological studies reported that most ND originate
from infections of the central nervous system (CNS)
and brain trauma [4–7]. The most common reported
ND in sub-Saharan Africa (SSA) include stroke, epi-
lepsy, meningitis, paraparesis, neuropathies, and trau-
matic brain injuries [8–10].
In 2010, Global Burden of Disease (GBD) report
indicated that non-communicable diseases (NCD)
accounted for 54% of global burden of disease (mor-
bidities and premature mortality); an increase from
43% in 1990 [11]. With the rapid epidemiological
transition in developing countries, mortalities asso-
ciated with age-related and lifestyle ND are expected
to increase in the presence of infection-related ND;
therefore, deliberate efforts in understanding the epi-
demiology of ND is necessary.
CONTACT Francis Levira flevira@ihi.or.tz Ifakara Health Institute, PO Box 78373, Dar es Salaam, Tanzania
GLOBAL HEALTH ACTION
2019, VOL. 12, 1596378
https://doi.org/10.1080/16549716.2019.1596378
© 2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits
unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The morbidity and mortality burden of stroke as an
example is reported to increase in developing countries,
accounting for 75% of global deaths and 81% stroke-
related Disability Adjusted Life Years (DALYs) [12].
In SSA, there is a paucity of national data on the
epidemiology of ND. Most references of national
estimates of the burden of NDs are cited from the
modeled estimates of GBD study. However, for most
developing countries, input parameters used in mod-
eling are obtained from inadequate vital registrations
records or small local studies. Coverage of mortality
and morbidity for China and India as an illustration
was only 15% and 1%, respectively, for mental, neu-
rological and substance abuse at the time GBD for
the year 2013 was estimated [13]. Model-based esti-
mates from GBD not only are free from coverage
limitations but also considerable reliance on geospa-
tial data and experts' opinions [12]. Global estimates
in some countries and cases deviate from the true
epidemiological profile and thus are deemed unreli-
able for local planning by policy makers [14].
Tanzania lacks national mortality data on ND due to
the insufficient coverage of civil and vital registration
systems as in many SSA countries [15,16]. Poor cover-
age of civil and vital registration systems at a national
level and over-reliance on global estimation have con-
cealed crucial statistics necessary in understanding
population health, improving health outcomes and
monitoring disease trends [17,18]. Several studies have
linked higher coverage of civil and vital statistics with
improved health outcomes in several countries [18].
In an effort to increase utilization of local data for
comprehensive health planning, the Tanzanian gov-
ernment was supported by development partners to
develop and implement a SAmple Vital registration
with Verbal AutopsY (SAVVY) study aimed at pro-
viding nationally representative estimates of mortality
and causes of death by sex, residence, and zone [19].
Nearly 75% of deaths occur at home in most devel-
oping countries and cause of death determination is
nearly absent in Tanzania as it is in many low- and
middle-income countries. Alternatively, the verbal
autopsy (VA) process facilitates generation of causes
of death statistics in situations where post-mortem
examinations and death certification are not routinely
conducted [20–22]. VA remained the only tool reli-
able for providing vital statistics information.
We examined the SAVVY data to estimate mor-
tality rates of the neurological disorders by sex, age,
residence, and zones in Tanzania.
Material and methods
Design and sampling
SAVVY is a community-based system implemented
in a nationally representative cluster sample [19].
Multistage random sampling was employed to select
23 districts, 1397 enumeration areas, and 154,603
households from mainland Tanzania, stratified by
residency and zones to meet the proposed overall
sample. The sampling frame for this study was
based on the 2002 Population and Housing Census
for Tanzania Mainland. A full description of design
and methods has been published elsewhere [23].
Figure 1 shows the map of Tanzania with shaded
sampled districts.
Baseline census
Baseline censuses were sequentially conducted in 23
districts between 2011 and 2014 in order to establish
denominators for estimating different demographic
indicators. During the baseline census, the sociode-
mographic information of the household members
was collected which included: age, sex, education,
and relationship to head of household. Deaths that
had occurred during the 12 months prior to the
census date were retrospectively documented in all
households.
Verbal autopsy
Verbal autopsy (VA) interviews were conducted for all
documented deaths by trained SAVVY VA coordina-
tors with the most appropriate person in the house-
hold after setting up an appointment. Standard verbal
autopsy questionnaires (2007 version) that have been
developed by the World Health Organization (WHO)
in collaboration with other stakeholders were used
[24]. Completed VA questionnaires were sent to phy-
sicians for a cause of death certification.
Physician’s assignment of causes of deaths
The cause of death for each interviewed death was
determined using the International Classification of
Diseases, tenth revision (ICD-10), as published by the
WHO [25]. Each VA questionnaire of the deceased
was reviewed independently by two physicians to
ascertain causes of deaths and produce death certifi-
cates. In case of discrepancies, two independent phy-
sicians met to resolve the discrepancies. If disagreed,
the cause of death was declared undetermined (mean-
ing there was no sufficient information to determine
the cause of death). Physicians reviewing VA ques-
tionnaires were medical doctors (not neurologists)
independent of the research institution trained on
death certification using ICD-10 classification.
Death certificates were requested and documented
during VA interviews. However, these certificates
were rarely available and coded in ICD-10; therefore,
for consistency reasons, we did not consider these
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certificates. Neurological causes of deaths were clas-
sified using code ranges of G00–G99 for diseases of
nervous system, I60–69 for cerebrovascular diseases,
P20 for intrauterine hypoxia, C71 for malignant neo-
plasm of brain, D33 for benign neoplasm of brain
and other parts of the CNS, Q00–Q07 for congenital
malformations of the nervous system, S06 for trau-
matic brain injuries/intracranial injury, and R25–R29
for symptoms and signs involving the nervous and
musculoskeletal systems [26,27].
Statistical analysis
National Population andHousing Census data were used
to provide a basis for data weighting. The gross weight
was estimated as the product of reciprocal of the prob-
ability of selection of districts within zones, enumeration
area (EA) within districts and households within EA.
Mortality rate was estimated as a weighted ratio of the
number of deaths and population. Cause-specific mor-
tality fraction (CSMF) was calculated as a ratio of deaths
due to a specific cause over the total number of deaths for
which cause of death information was available. CSMF
were compared across the subpopulation by calculating
the mortality rate fraction (MRF), which is the ratio of
two CSMF. Females, urban, and age 50 and above and
lake zone were set as the reference category for CSMF
comparisons. Lake zone is known to have poor interven-
tion coverage for a substantial number of health systems
performance indicators; therefore, we set it as a reference
category [28].
Results
A total of 650,864 residents in 154,603 households were
enrolled during the baseline census survey. There were
91,329 (51%) households in rural areas and 63,274 (41%)
in urban areas. The majority of households were headed
by males (72%). The average household size was 4.5 in
rural areas and 3.7 in urban areas. A total of 6645 deaths
were documented to have occurred 12 months prior to
the baseline survey corresponding to an annual weighted
crude death rate of 10.8 (95% CI: 10.8–10.9) deaths per
1000 population. Teh age distribution of the reported
deaths is shown in death pyramid in Figure 2.
VA interviews were conducted for 6608 (99%) of the
documented 6645 deaths. Causes of death certification
were completed for 5225 (79%) of 6608 VA interviewed
deaths. Of 5225 deaths with complete cause of death,
872 (17%) were newborn aged 0–29 days (VA form 1),
1096 (21%) were children aged 29 days−14 years (VA
form 2) and 3257 (62%) were adults older than 15 years
(VA form 3). Causes of death could not be ascertained
for 1383 deaths due to absence of a reliable caregiver to
respond to the VA interview, incomplete VA inter-
views, and incomplete cause of death determination
by physicians, among other things.
Causes of neurological deaths
A total of 261 neurological deaths were determined; 72
(27.6%) were children younger than 5 years, 22 (8.4%)
were children aged 5–19 years, 65 (24.9%) were adults
aged 20–49 years, and 102 (39.1%) were adults older
Figure 1. Geographic locations of 23 SAVVY districts on a map of Tanzania.
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than 50 years. All neurological deaths were coded into
30 three- or four-digit ICD-10 causes and later grouped
into nine major categories of cerebrovascular diseases,
meningitis, epilepsy, cerebral palsy and other paralytic
syndromes, intrauterine hypoxia, malignant and benign
neoplasms of brain and CNS, congenital malformations
of the nervous system, other neurological disorders, and
symptoms and signs involving the nervous and muscu-
loskeletal systems (Table 1).
Neurological disorders mortality
Of the reported ND-related deaths, the leading causes
were cerebrovascular diseases (33.0%), epilepsy
(18.4%), meningitis (16.1%), cerebral palsy and other
paralytic syndromes (CP) (9.2%), and intrauterine
hypoxia (IH) (6.9%). All causes mortality of ND was
estimated with a CSMF of 4.99% (95% CI: 4.40–5.59)
(Table 2). There were no differences in CSMF among
males (4.76%) and females (5.27%) (MRF = 0.90, 95%
CI: 0.70–1.16). Compared to adults aged 50 years and
above, mortality of ND was estimated to be lower
among children aged 0–4 (MRF = 0.71, 95% CI:
0.52–0.97), and comparable in children aged 5–19
(MRF = 1.07, 95% CI: 0.64–1.72) and adults aged
20–49 (MRF = 1.07, 95% CI: 0.64–1.72). Mortality was
lower by 23.0% in urban (4.35%) than rural (5.63%)
areas (MRF = 0.77, 95% CI: 0.40–0.99). Mortality of ND
was comparable across zones. Using census population
and crude death rate of 2012 and CSMF observed in this
study, we estimated the number of neurological deaths
to range from 18,000 to 22,000 in Tanzania in 2012.
Cerebrovascular mortality
Cerebrovascular diseases are a category of a broader
group of diseases of the circulatory system.
Cerebrovascular diseases accounted for 19.0% of all
deaths from diseases of circulation, after hypertension
which accounted for 66.0% of deaths from diseases of
circulation. A total of 86 cerebrovascular deaths were
reported out of 5225 certified deaths. Among those
who died of cerebrovascular diseases, stroke was the
leading cause of death, constituting 92.0% of all
reported cerebrovascular deaths. The remaining
8.0% constituted hypertensive encephalopathy, seque-
lae of stroke not specified as hemorrhage or infarc-
tion, and sequelae of other unspecified
cerebrovascular diseases.
The mortality of cerebrovascular-related deaths
was estimated with a CSMF of 1.64% (95% CI:
1.30–1.99); with a higher estimate in adults older
than 50 years (3.82%) than adults aged 20–49
(1.31%) (MRF = 3.4, 95% CI: 1.19–5.58) (Table 2).
There was a comparable estimate in urban (1.98%)
and rural (1.32%) populations (MRF = 1.5, 95% CI:
0.95–2.37). No significant differences were observed
between lake zone and other zones.
In adults older than 50 years, the mortality of cere-
brovascular-related deaths was estimated with a CSMF
of 3.82% (95% CI: 2.92–4.72). CSMF was lower in
males (2.87%) than females (4.93%) (MRF = 0.58,
95% CI: 0.34–0.97), comparable in urban (4.19%) and
rural (3.42%) (MRF = 1.23, 95% CI: 0.73–2.06), and
lower in central zone (1.68%) compared to lake zone
(6.22%) (MRF = 0.27, 95% CI: 0.08–0.76).
Epilepsy mortality
Of all ND-related deaths, epilepsy accounted for 18.4%;
4.2% among children < 5 years, 40.9% among children
aged 5–19, 36.9% among adults aged 20–49, and 11.8%
among adults older than 50 years (Table 1). Unspecified
convulsive epilepsy (98.0%) and other generalized
Figure 2. Age distribution of 6645 reported deaths (3509 males and 3136 females) from SAVVY districts.
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epilepsy and unspecified epileptic syndromes (2.0%)
were the category reported for all deaths.
Of 5225 certified deaths, 49 were epilepsy-related
with a CSMF of epilepsy of 0.94% (95% CI:
0.68–1.20) with significantly higher estimates in
males (1.28%) than females (0.54%) (MRF = 2.37,
95% CI: 1.23–4.88) (Table 3). Epilepsy mortality was
higher in children aged 5–19 (MRF = 3.45, 95% CI:
Table 1. Distribution of causes of neurological death by age group.
Age group
<5 5–19 20–49 50+ All ages
Cerebrovascular diseases 1.4 27.7 65.7 33.0
Stroke, not specified as hemorrhage or infarction 1.4 24.6 60.8 30.3
Hypertensive encephalopathy 1.0 0.4
Sequelae of stroke, not specified as hemorrhage or infarction 3.1 2.9 1.9
Sequelae of other and unspecified cerebrovascular diseases 1.0 0.4
Epilepsy 4.2 40.9 36.9 11.8 18.4
Other generalized epilepsy and epileptic syndromes 1.0 0.4
Epilepsy, unspecified 4.2 40.9 36.9 11.8 18.4
Meningitis 34.7 22.7 10.8 4.9 16.1
Bacterial meningitis, not elsewhere classified 4.2 1.2
Meningitis due to other and unspecified causes 1.4 0.4
Meningitis, unspecified 29.2 22.7 10.8 4.9 14.6
Cerebral palsy and other paralytic syndromes 11.1 18.2 3.1 9.8 9.2
Cerebral palsy 1.4 0.4
Cerebral palsy, unspecified 8.3 13.6 3.5
Hemiplegia, unspecified 4.9 1.9
Paraplegia, unspecified 4.6 1.5 2.9 1.9
Paralytic syndrome, unspecified 1.4 1.5 2.0 1.5
Intrauterine hypoxia 25.0 6.9
Malignant and benign neoplasms of brain and CNS 9.1 7.7 1.0 3.1
Malignant neoplasm of brain 3.1 0.8
Malignant neoplasm of spinal cord, cranial nerves, and other parts of CNS 9.1 3.1 1.0 1.9
Benign neoplasm of brain and other parts of central nervous system 1.5 0.4
Congenital malformations of the nervous system 12.5 1.5 3.8
Congenital hydrocephalus 1.4 0.4
Congenital hydrocephalus, unspecified 4.2 1.5 1.5
Spina bifida 1.4 0.4
Spina bifida, unspecified 4.2 1.2
Congenital malformation of nervous system, unspecified 1.4 0.4
Other neurological disorders 4.2 6.2 2.9 3.8
Migraine 1.0 0.4
Migraine, unspecified 3.1 1.0 1.2
Polyneuropathy, unspecified (neuropathy NOS) 1.5 1.0 0.8
Hydrocephalus 4.2 1.5 1.5
Symptoms and signs involving the nervous
and musculoskeletal systems
6.9 9.1 6.2 2.9 5.4
Other and unspecified symptoms and signs involving
the nervous and musculoskeletal systems
1.0 0.4
Headache 6.2 2.0 2.3
Other and unspecified convulsions 6.9 9.1 2.7
Number of deaths 72 22 65 102 261
Table 2. Cause-specific mortality fraction (%) estimates of neurological disorders and epilepsy by sex, age, residency, and zone.
Neurological disorders Epilepsy
Deaths CSMF (95% CI) MRF (95% CI) Deaths CSMF (95% CI) MRF (95% CI)
Sex
Males 134 4.76 (4–5.55) 0.90 (0.70–1.16) 36 1.28 (0.86–1.69) 2.37 (1.23–4.88)
Females 127 5.27 (4.38–6.16) 13 0.54 (0.25–0.83)
Age
<5 72 4.13 (3.19–5.06) 0.71 (0.52–0.97) 3 0.17 (0–0.37) 0.23 (0.04–0.84)
5–19 22 6.25 (3.72–8.78) 1.07 (0.64–1.71) 9 2.56 (0.91–4.20) 3.45 (1.30–8.72)
20–49 65 4.72 (3.6–5.84) 0.81 (0.58–1.12) 24 1.74 (1.05–2.43) 2.35 (1.15–5.03)
50+ 102 5.82 (4.72–6.91) 13 0.74 (0.34–1.14)
Residency
Rural 149 5.63 (4.75–6.50) 30 1.13 (0.73–1.54) 0.65 (0.35–1.19)
Urban 112 4.35 (3.56–5.13) 0.77 (0.60–0.99) 19 0.74 (0.41–1.07)
Zone
Western 31 4.74 (3.11–6.37) 0.75 (0.46–1.21) 7 1.07 (0.28–1.86) 1.00 (0.31–3.16)
Northern 25 3.53 (2.17–4.88) 0.56 (0.33–0.93) 3 0.42 (0–0.90) 0.40 (0.07–1.65)
Central 43 4.68 (3.31–6.04) 0.74 (0.48–1.15) 12 1.30 (0.57–2.04) 1.22 (0.46–3.45)
Southern Highlands 39 6.61 (4.60–8.61) 1.05 (0.67–1.64) 4 0.68 (0.01–1.34) 0.63 (0.14–2.37)
Eastern 43 4.8 (3.41–6.21) 0.77 (0.49–1.18) 8 0.89 (0.28–1.51) 0.84 (0.27–2.56)
Southern 33 4.65 (3.10–6.20) 0.74 (0.46–1.18) 7 0.99 (0.26–1.71) 0.92 (0.28–2.91)
Lake 47 6.27 (4.54–8.01) 8 1.07 (0.33–1.80)
Overall 261 4.99 (4.40–5.58) 49 0.94 (0.68–1.20)
Ref: Reference category; CSMF: cause-specific mortality fraction, MRF, mortality rate fraction; CI: confidence interval.
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1.30–8.72) and adults aged 20–49 (MRF = 2.35, 95%
CI: 1.15–5.03) than adults aged 50 years and above.
Epilepsy mortality was observed to be comparable in
urban (0.74%) and rural (1.13%) areas (MRF = 0.65,
95% CI: 0.35–1.19). Epilepsy mortality was also com-
parable across zones.
Meningitis mortality
Bacterial meningitis accounted for 16.1% of all ND
deaths; 34.7% among children < 5 years, 22.7%
among children aged 5–19, 10.8% among adults
aged 20–49, and 4.9% among adults older than 50
years (Table 1). No viral-related meningitis deaths
were identified by physicians.
Of certified deaths, meningitis-related mortality was
estimated with a CSMF of 0.80% (95% CI: 0.56–1.04)
(Table 4). Compared to adults older than 50 years
(CSMF = 0.28%), meningitis mortality was high in
children 0–4 (1.43%) (MRF = 5.02, 95% CI:
1.89–16.81) and those aged 5–19 years (1.42%) (CSMF
= 4.98, 95% CI: 1.15–21.64). Meningitis mortality was
comparable in urban (0.66%) and rural (0.94%) (MRF =
0.70, 95% CI: 0.35–1.35) areas and among males
(1.04%) and females (0.79%) (MRF = 1.04, 95% CI:
0.54–2.04).
Subanalysis of meningitis mortality in children
similar to the above indicated no differences in
CSMF related to sex, age, residency, and zone.
Cerebral palsy and other paralytic syndromes
CP accounted for 9.2% of all ND deaths; 11.1% among
children < 5 years, 18.2% among children aged 5–19,
3.1% among adults aged 20–49, and 9.8% among
adults older than 50 years (Table 1). Cerebral palsy
deaths were reported in children younger than 20
years while paralytic syndromes (hemiplegia, paraple-
gia, and paralysis) were common in adults older than
20 years. A total of 24 deaths from CP and other
paralytic syndromes were identified with a CSMF of
0.46% (95% CI: 0.27–0.65). Mortality of cerebral palsy
in children younger than 5 years was estimated with
a CSMF of 0.40% (95% CI: 0.10–0.70).
Intrauterine hypoxia
A total of 18 deaths from IH were coded. IH
accounted for 6.9% of all ND deaths and 25.0%
among children younger than 5 years died of ND.
Given the fact that IH is diagnosed at birth or the
early days of neonatal life, mortality associated with
IH in neonates was estimated with a CSMF of 2.06%
(95% CI: 1.12–3.01).
The remaining ND-related deaths were broadly
grouped as malignant and benign neoplasms of the
brain and CNS, congenital malformations of the nervous
system, other neurological disorders, and symptoms and
signs involving the nervous andmusculoskeletal systems.
The mortality of these ND combined were estimated
with a CSMF of 0.80% (95% CI: 0.56−1.04). Malignant
and benign neoplasms of the brain and CNS were
reported and estimated in individuals aged < 5 years
with a CSMF of 0.23% (95% CI: 0.07–0.39). Congenital
malformations of the nervous system were reported and
estimated in children < 5 years with a CSMF of 0.52%
(95% CI: 0.18–0.85).
Discussion
This study provides the first detailed analysis of national
data on neurological disorders in Tanzania. The study
utilized a SAVVY approach developed to provide
a standardized methodology in generating mortality
Table 3. Cause-specific mortality fraction (%) estimates of cerebrovascular disorders (95% CI) by sex, age, residency, and zone.
Cerebrovascular diseases Cerebrovascular diseases (50+ years)
Deaths CSMF (95% CI) MRF (95% CI) Deaths CSMF (95% CI) MRF (95% CI)
Sex
Males 38 1.99 (1.43–2.55) 27 2.87 (1.80–3.93) 0.58 (0.34–0.97)
Females 48 1.35 (0.92–1.78) 0.68 (0.43–1.06) 40 4.93 (3.44–6.42)
Age
<5 1 0.06 (0.00–0.17) 0.02 (0.00–0.09)
5–19 0
20–49 18 1.31 (0.71–1.91) 0.34 (0.19–0.58)
50+ 67 3.82 (2.92–4.72)
Residency
Rural 35 1.32 (0.89–1.76) 29 3.42 (2.20–4.65)
Urban 51 1.98 (1.44–2.52) 1.50 (0.95–2.37) 38 4.19 (2.89–5.50) 1.23 (0.73–2.06)
Zone
Western 11 2.14 (1.10–3.17) 0.79 (0.33–1.81) 9 6.08 (2.23–9.93) 0.99 (0.37–2.47)
Northern 9 1.27 (0.44–2.09) 0.59 (0.23–1.43) 7 2.30 (0.62–3.99) 0.37 (0.12–1.00)
Central 8 0.87 (0.27–1.47) 0.41 (0.15–1.01) 6 1.68 (0.35–3.01) 0.27 (0.08–0.76)
Southern Highlands 12 2.03 (0.89–3.17) 0.95 (0.41–2.14) 10 6.54 (2.62–10.45) 1.05 (0.41–2.59)
Eastern 18 2.01 (1.09–2.93) 0.94 (0.45–1.98) 12 3.87 (1.72–6.02) 0.62 (0.26–1.48)
Southern 12 1.69 (0.74–2.64) 0.79 (0.34–1.78) 10 3.68 (1.44–5.91) 0.59 (0.23–1.46)
Lake 16 1.68 (0.70–2.67) 13 6.22 (2.94–9.49)
Overall 86 1.64 (1.30–1.99) 67 3.82 (2.92–4.72)
Ref: Reference category; CSMF: cause-specific mortality fraction; MRF: mortality rate fraction; CI: confidence interval.
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estimates, causes of death and disease classification
needed for local, regional and international comparabil-
ity of mortality statistics. The adopted approach, which
included national random samples of enumeration
areas provided by the National Bureau of Statistics
(NBS), multistage sampling methodology, use of two
independent causes-of-death certifiers and ICD-10
guarantee credibility of the study's findings.
The main neurological disorders identified were cer-
ebrovascular diseases, epilepsy, meningitis, cerebral
palsy and other paralytic syndromes, and intrauterine
hypoxia. Cerebrovascular disorders were the leading
cause of death, most of which were attributed to stroke.
We estimated that the number of neurological deaths in
Tanzania ranged from 18,000 to 22,000 in 2012.
Cerebrovascular diseases
Hypertensive diseases are the major risk factor for ND,
specifically stroke and dementia [29]. The STEPwise
approach to Surveillance (STEPS) survey designed by
WHO estimated high blood pressure (>140/90 mmHg)
in 25.9% of adults aged 25–64 years in Tanzania in 2012
[30]. High mortality estimates attributed to hyperten-
sion and cerebrovascular disorder observed in SAVVY
are incoherent with the prevalence of hypertension
reported in STEPS survey. A recent hospital mortality
study for Tanzania mainland reported an increase of
stroke-relatedmortality to 27% between 2006–2010 and
2011–2015. In the study period from 2006 to 2015,
deaths attributable to stroke were 3.1% while cardior-
espiratory and cardio-circulatory diseases accounted for
6.6% and 5.6%, respectively [31]. Comparable estimates
of cerebrovascular mortality by residency in this study
indicate lifestyle-related diseases equally affect rural and
urban residents. These observations deviate from the
common knowledge that urban residents are at higher
risk for NCD in general compared to rural residents.
Insufficient coverage of human resources and medicine
supply for cardiovascular diseases may also explain why
Tanzania lags behind in slowing down the increasing
trends in the majority of NCD. In 2014, the Tanzania
Service Provision Assessment Survey (TSPA) indicated
a lack of guidelines for healthcare providers for NCD
services [32]. The TSPA indicated that less than 10% of
facilities have providers who have recently received
training in providing services for cardiovascular and
other chronic diseases [32]. Despite the fact that major-
ity of Tanzanians access their health services through
dispensaries and health facilities, the TSPA indicated
the that availability of essential medicines for cardio-
vascular and other chronic diseases is lower in most
dispensaries and health facilities than in hospitals.
Epilepsy
The population estimate of 7.3 (95% CI: 6.9–7.6) deaths
per 100,000 was comparable to estimates in the three
large demographic surveillance sites: 5.4 (95% CI:
4–6.7) in Rufiji, 7.9 (95% CI: 6.1–9.7) in Ifakara Rural
and 3.9 (95%CI: 1.3–6.4) deaths per 100,000 population
in Ifakara Urban [33]. Epilepsy mortality rate and
CSMFwere comparable to estimates reported elsewhere
in most developing countries. The majority of interven-
tions targeting epilepsy are those aimed at eliminating
the Taenia solium tapeworm, which is responsible for
the development of taeniosis, a major cause of preven-
table epilepsy [34,35]. In Tanzania, the National
Schistosomiasis Control Program (NSCP) routinely
implemented school-based mass drug administration
targeting both schistosomiasis and Taenia solium [36].
Several interventions have been devised to reduce para-
site infections in Tanzania; however, most of these
Table 4. Cause-specific mortality fraction (%) estimates of meningitis disorders by sex, age, residency, and zone.
Meningitis Meningitis (age 0–19)
Deaths CSMF(95% CI) MRF (95% CI) Deaths CSMF (95% CI) MRF (95% CI)
Sex
Males 23 0.82 (0.48–1.15) 1.04 (0.54–2.04) 18 1.57 (0.85–2.29) 1.25 (0.57–2.84)
Females 19 0.79 (0.43–1.14) 12 1.26 (0.55–1.97)
Age
<5 25 1.43 (0.88–1.99) 5.02 (1.89–16.81) 1.43 (0.88–1.99) 1.01 (0.38–3.37)
5–19 5 1.42 (0.18–2.66) 4.98 (1.15–21.64) 25 1.42 (0.18–2.66)
20–49 7 0.51 (0.13–0.88) 1.78 (0.49–7.13) 5
50+ 5 0.28 (0.03–0.53)
Residency
Rural 25 0.94 (0.57–1.31) 19 1.57 (0.87–2.27)
Urban 17 0.66 (0.35–0.97) 0.70 (0.35–1.35) 11 1.24 (0.51–1.97) 0.79 (0.34–1.75)
Zone
Western 5 0.76 (0.10–1.43) 0.67 (0.17–2.11) 5 1.26 (0.16–2.37) 0.58 (0.15–2.01)
Northern 4 0.56 (0.01–1.11) 0.47 (0.10–1.68) 1 0.56 (0.00–1.65) 0.25 (0.01–1.91)
Central 1 0.11 (0.00–0.32) 0.09 (0.00–0.65) 0
Southern Highlands 14 2.37 (1.14–3.60) 1.97 (0.80–5.17) 12 4.33 (1.93–6.73) 0.04 (0.02–0.03)
Eastern 5 0.56 (0.07–1.05) 0.46 (0.12–1.55) 1 0.31 (0.00–0.91) 0.14 (0.00–1.05)
Southern 4 0.56 (0.01–1.11) 0.47 (0.10–1.68) 3 1.39 (0.00–2.95) 0.64 (0.11–2.65)
Lake 9 1.20 (0.42–1.98) 8 2.18 (0.69–3.68)
Overall 42 0.80 (0.56–1.04) 30 1.43 (0.92–1.94)
Ref: Reference category; CSMF: cause-specific mortality fraction; MRF: mortality rate fraction; CI: confidence interval.
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interventions have proved to yield modest efficacy, and
therefore need to be re-evaluated [37].
Despite these efforts, mortality of epilepsy has
remained stable over the years in Tanzania with refer-
ence to the previous national demographic surveillance
system’s study conducted in 1992–1995, which estimated
an epilepsy mortality rate of 15 and 5 deaths per 100,000
population in males and females, respectively [38].
Probable contributors to stagnation in reduction of
epilepsy mortality include the rise of cerebrovascular
diseases attributed to epilepsy such as stroke, the
increase in emerging infectious diseases such as
HIV, and an increase in traumatic brain injuries as
a result of wide use of bikes/motor bikes without
a helmet and vehicles without a seatbelt. These factors
probably explain why in this study we have more
mortality due to epilepsy in adults than in children,
who normally have more epilepsy in general in SSA,
especially those originating from febrile seizures.
Meningitis
The mortality of meningitis was low, accounting for less
than <0.8% of all deaths and 1.5% in children aged
younger than 5 years. Analysis of WHO-reported cases
of meningitis in Africa identified 11 regions (the ‘menin-
gitis belt’) that account for 90% of all meningitis in SSA
(Tanzania not included) [39]. High meningitis mortality
in children may be explained by the fact that the menin-
gitis pathogen that accounts for most cases of acute
bacterial meningitis affects neonates and children.
Observed meningitis deaths in adults may mostly con-
stitute AIDS or TB-related deaths based on the fact that
meningitis (cryptococcal) is a leading cause of death
among HIV-infected individuals in SSA and in the stu-
died population, where the latest HIV prevalence was
estimated in adults aged 15–49. However, the unexpected
lowmortality ofmeningitis in adultsmay be explained by
the fact that meningitis may be reported as immediate
but not the underlying cause of death. The analysis in this
study focused on underlying causes of death.
Cerebral palsy and other paralytic syndromes
Cerebral palsy is a lifelong disability in children of
non-progressive brain damage which most likely
occurred during the antenatal, perinatal, or early
postnatal period. Clinical presentations include chal-
lenges in coordination, stiff and/or weak muscles,
tremors, and in some cases problem s in sense organs
and reasoning. The burden of CP in Africa is esti-
mated at 2–2.5 cases per 1000 live births and globally
affects 0.2% of neonates [40,41]. Improving care at
birth may have potential in reducing perinatal
adverse events that are likely to result in the develop-
ment of this disorder. There are scarce data on mor-
tality in cerebral palsy in Africa, hence this study
provides valuable statistics for future studies of the
disorder.
Mortality from paralytic syndromes (including
hemiplegia and paraplegia) was more common in
individuals older than 50 years. These disorders may
be sequelae of stroke, degenerative diseases, or infec-
tion of the nervous system; therefore, further investi-
gation of its epidemiology is needed.
Intrauterine hypoxia
In general, IH is the form of birth asphyxia that
affects the brain as a result of oxygen deprivation of
the fetus [42]. Birth asphyxia is a more general term,
and we anticipate that most clinicians would classify
IH as birth asphyxia. Despite the possibility for mis-
classification, physicians were able to capture IH
deaths, which were the second leading cause of neu-
rological death in children under 5 years. Poor mater-
nal health condition, fetus development, and adverse
perinatal events are the major culprits for the devel-
opment of these disorders [42]. Improving antenatal
and care at birth by scaling-up facility delivery and
improving basic and comprehensive emergency
obstetric and newborn care may significantly reduce
pregnancy- or birth-related neurological morbidities
such as cerebral palsy and mortality.
Comparison with modeled estimates
Our estimates were lower or higher than those
reported by GBD reports (Table 5) [43]. The esti-
mated CSMFs of cerebrovascular diseases were
comparable to estimates from the GBD for adults
aged 15–49 years and close to estimates for all ages.
Table 5. Cause-specific mortality fraction (%) comparison of neurological disorders by study.
Age 0–4 years Age 15–49 years All ages
SAVVY GBD SAVVY GBD SAVVY GBD
Cerebrovascular 0.02 (0.00–0.09) 0.07 (0.04–0.09) 1.20 (0.65–1.92) 1.23 (0.96–1.76) 1.64 (1.30–1.99) 3.16 (2.66–3.63)
Epilepsy 0.17 (0–0.37) 0.11 (0.08–0.14) 1.94 (1.24–2.64) 0.55 (0.43–0.69) 0.94 (0.68–1.20) 0.25 (0.22–0.30)
Meningitis 1.43 (0.88–1.99) 3.53 (2.30–6.07) 0.53 (0.16–0.91) 1.53 (1.06–2.23) 0.80 (0.56–1.04) 2.10 (1.61–2.94)
Road injuries 0.28 (0.04–0.54) 0.54 (0.36–0.84) 5.83 (4.64–7.01) 2.41 (1.89–2.99) 2.43 (2.01–2.84) 1.48 (1.29–1.67)
Legend:
Data sources
SAVVY: Analysis of Sample vital registration with verbal autopsy
GBD: Extracted from Global Burden of Disease report
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SAVVY estimates of deaths attributable to epilepsy
and road traffic injuries were higher in all age
categories and overall than those reported in the
GBD. On the other hand, the GBD reported higher
estimates for deaths attributable to meningitis. The
observed differences may be linked to methodolo-
gical limitations in both approaches; however,
SAVVY estimates are more likely to be closer to
true population estimates. A substantial proportion
of data used in generating the GBD for Tanzania
are those derived from health and demographic
surveillance systems, most of which are located in
poor rural areas [44,45]. Recently, the 2017 GBD
report in Tanzania compiled cerebrovascular disea-
sesdata dated from 2010 to 1993 due to the limited
number of studies and poor coverage of civil and
vital registration systems [46].
Limitations
Missing and misclassifying neurological disorders was
the main possible limitation of this study attributed
to lack of clinical training in neurology among phy-
sicians conducting death certification. A substantial
proportion of deaths were coded as malaria in this
study; however, some of the clinical manifestations of
cerebral malaria such as fever, vomiting, and convul-
sions are also clinical manifestations of neurological
disorders such as meningitis and epilepsy. Other pos-
sible misclassifications include those related to mis-
classifying cerebrovascular disorder as hypertensive
disease, or vice versa. We did not observe traumatic
brain injuries or intracranial deaths in this study
despite the high mortality of road injuries estimated
at 2.4% in all ages and 5.8% (95% CI: 4.7–7.1) in
adults aged 15–49 years (results not reported but
provided for contextual reasoning). Road injuries
are one of the main causes of brain injuries; therefore,
lack of information from VA or medical records may
have resulted in missing some traumatic brain
injury deaths in this study [9,10,47]. With regards
to comparability of this study across countries,
regions, and internationally, adoptions of newer ver-
sions of ICD-10 and the tabulation list of neurologi-
cal disorders are likely to result in different mortality
estimates elsewhere [48]. The recent version of ICD-
10 recommends grouping some hypertensive disor-
ders as cerebrovascular deaths; such changes are
likely to result in estimates that are incomparable to
what was observed in this study [49].
Conclusions
The SAVVY survey provided estimates mortality burden
of neurological disorders in Tanzania to the level of
zones. Cerebrovascular diseases, epilepsy, meningitis,
cerebral palsy and other paralytic syndromes, and
intrauterine hypoxia are the leading causes of neurologi-
cal mortality in Tanzania. The SAVVY sampling design
strengthens the study in terms of representativeness for
the nation and reliability of cause-of-death determina-
tion, and provides national baseline data on epidemiolo-
gical information on neurological disorders needed for
prevention and intervention programs. These estimates
are rare in most SSA; therefore, we believe our archived
data sets will contribute to advancing knowledge of neu-
rological disorders. On the other hand, the burden asso-
ciated with morbidities of neurological disorders might
be far higher than that of mortality. In the case of stroke,
mortality rates and deaths have substantially declined in
most countries; however, the number of people living
with stroke-related disabilities has been increasing.
Reliable morbidity data can only be obtained when
there is routine healthcare services data of good quality
and community-based surveys. Integrating measures of
morbidities such as DALYs in SAVVY design may pro-
vide a complete picture of disease, social and economic
burden not only of neurological disorders but also of
other prevalent diseases.
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Paper context
In the context of low- and middle-income countries, it
has been established that the majority of neurological
disorders are linked to infections and brain injuries.
However, in the context of epidemiological transition,
we hypothesize that there is high emerging incidence of
age-related neurological disorders such as dementia, cere-
brovascular and heart diseases. We utilize a SAVVY
study; a national representative sample and explore mor-
tality of neurological disorders in Tanzania by sex, resi-
dence, and special geographic areas (zone).
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